陰道念珠菌症治療市場：依藥物類型、給藥途徑、通路及地區分類

Vaginal Fungi Infections Treatment Market, By Drug Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，陰道念珠菌症治療市場規模將達到 13.475 億美元，到 2033 年將達到 19.359 億美元。預計從 2026 年到 2033 年，該市場將以 5.4% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	13.475億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.40%	2033年市場規模預測：	19.359億美元

陰道念珠菌症是一種真菌感染疾病導致陰道和外陰部（陰道口周圍的組織）出現刺激、分泌物和劇烈搔癢。它也被稱為陰道念珠菌症、外陰陰道念珠菌症、念珠菌性陰道炎或陰道念珠菌症，根據美國疾病念珠菌症與預防中心（CDC）的數據，它是美國第二大常見的陰道感染疾病。

市場動態

陰道念珠菌症發病率的上升正在推動陰道念珠菌症病治療市場的成長。例如，根據美國疾病管制與預防中心（CDC）2018年的數據，美國每年約有140萬例陰道念珠菌症病門診就診。此外，根據多學科數位出版機構（MDPI）2020年2月發表的報導，外陰陰道念珠菌症（VVC）是人類最常見的念珠菌感染疾病，全球約75%的女性一生中至少會患上一次。此外，根據相同資訊來源，全球約有8%的女性患有復發性外陰陰道念珠菌症（RVVC）。

然而，治療陰道真菌感染疾病的替代療法可能會阻礙市場成長。例如，營養補充劑和個人護理用品公司Nutrablast提供用於治療陰道真菌感染疾病的茶樹栓劑。本產品採用天然茶樹油，旨在恢復陰道環境的平衡。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新藥上市和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的關鍵見解。
本研究根據以下參數對全球陰道念珠菌症治療市場的主要參與者進行了分析：公司概況、財務業績、產品系列、市場佔有率、分銷策略、主要發展、策略和未來計劃。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的藥物上市、藥物類別升級、市場擴張和行銷策略做出明智的決策。
這份《全球陰道念珠菌症治療市場》報告旨在為該行業的各種相關人員提供參考，包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
透過分析全球陰道念珠菌症治療市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第8章競爭情勢

熱圖分析
市佔率分析
- Pfizer Inc.
- Bausch Health Companies Inc
- ANI Pharmaceuticals, Inc.
- Hikma Pharmaceuticals Plc
- Lupin Limited
- Mycovia Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Limited
- Unique Pharmaceuticals
- PEPTONIC medical AB
- Aurobindo Pharma Limited
- Reddy's Laboratories
- SCYNEXIS, Inc.

第9章

參考
調查方法

簡介目錄

Product Code: CMI4271

Vaginal Fungi Infections Treatment Market is estimated to be valued at USD 1,347.5 Mn in 2026 and is expected to reach USD 1,935.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,347.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.40%	2033 Value Projection:	USD 1,935.9 Mn

A vaginal yeast infection is a fungal infection that causes irritation, discharge, and intense itchiness of the vagina and the vulva - the tissues at the vaginal opening. Vaginal fungi infection is also known as vaginal yeast infection, vulvovaginal candidiasis, candidal vaginitis or vaginal candidiasis, and it the second most common type of vaginal infection in the U.S., according the Centers for Disease Control and Prevention.

Market Dynamics

Rising incidence of vaginal fungi infections are driving vaginal fungi infections treatment market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), 2018, around 1.4 million outpatient visits occur for vaginal candidiasis every year in the U.S. Moreover, according to an article published in Multidisciplinary Digital Publishing Institute (MDPI) in February 2020, Vulvovaginal candidiasis (VVC) is the most prevalent human candidal infection and nearly 75% women across the globe are affected by it least once in their lifetime. Furthermore, according to the same source, around 8% women across the globe suffer from Recurrent Vulvovaginal Candidiasis (RVVC).

However, alternative therapies for vaginal fungi infections treatment can hinder the market growth. For instance, Nutrablast, a dedicated company in the dietary supplement and personal care offers Tea Tree Suppositories for vaginal fungi infections treatment. The product is natural tea tree oil to provide a balanced vaginal environment.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Vaginal Fungi Infections Treatment Market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, and SCYNEXIS, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global Vaginal Fungi Infections Treatment Market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaginal fungi infections treatment market.

Market Segmentation

By Drug Type (Revenue, USD Mn, 2021-2033)
- Fluconazole
- Nystatin
- Flucytosine
- Others
By Route of Administration (Revenue, USD Mn, 2021-2033)
- Oral
- Topical
By Distribution Channel (Revenue, USD Mn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies.
By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Competitive Landscape
- Pfizer Inc.
- Bausch Health Companies Inc
- ANI Pharmaceuticals, Inc.
- Hikma Pharmaceuticals Plc
- Lupin Limited, Mycovia Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Limited
- Unique Pharmaceuticals
- PEPTONIC medical AB
- Aurobindo Pharma Limited
- Reddy's Laboratories
- SCYNEXIS, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
Regulatory Scenario
New Product Launches
Collaborations and Agreements
Market Trends

4. Global Vaginal Fungi Infections Treatment Market, By Drug Type, 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Fluconazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
Nystatin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
Flucytosine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)

5. Global Vaginal Fungi Infections Treatment Market, By Route of Administration, 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)

6. Global Vaginal Fungi Infections Treatment Market, By Distribution Channel, 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Mn)

7. Global Vaginal Fungi Infections Treatment Market, By Region, 2021- 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
North America
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021- 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Drug Type, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021- 2033, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2021- 2033, (US$ Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Bausch Health Companies Inc
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- ANI Pharmaceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Hikma Pharmaceuticals Plc
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Lupin Limited
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Mycovia Pharmaceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Glenmark Pharmaceuticals Limited
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Unique Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- PEPTONIC medical AB
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Aurobindo Pharma Limited
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Reddy's Laboratories
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- SCYNEXIS, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Analyst Views